Literature DB >> 24634854

Cancer stem cells in glioma: challenges and opportunities.

Jialiang Wang1, Yufang Ma2, Michael K Cooper3.   

Abstract

The discovery of cancer stem cells in glioma has created a paradigm shift in our understanding of this deadly disease. Glioma stem cells exhibit sustained self-renewal and potent tumorigenic potential and differ from their more differentiated progeny in response to current therapies. Recurrent disease is likely derived from glioma stem cells or progeny reprogrammed to gain stem cell-like phenotypes, indicating that the stem cell phenotype is a crucial therapeutic target. While debate over cancer stem cell and clonal evolution models persists, important knowledge has been gained over the past decade from glioma stem cells investigation and clinical impact is expected.

Entities:  

Keywords:  Glioma; cancer stem cells

Year:  2013        PMID: 24634854      PMCID: PMC3952560          DOI: 10.3978/j.issn.2218-676X.2013.08.01

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


  143 in total

1.  A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

Authors:  Ruihuan Chen; Merry C Nishimura; Stephanie M Bumbaca; Samir Kharbanda; William F Forrest; Ian M Kasman; Joan M Greve; Robert H Soriano; Laurie L Gilmour; Celina Sanchez Rivers; Zora Modrusan; Serban Nacu; Steve Guerrero; Kyle A Edgar; Jeffrey J Wallin; Katrin Lamszus; Manfred Westphal; Susanne Heim; C David James; Scott R VandenBerg; Joseph F Costello; Scott Moorefield; Cynthia J Cowdrey; Michael Prados; Heidi S Phillips
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

2.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources.

Authors:  R F Keeler; W Binns
Journal:  Teratology       Date:  1968-02

Review 4.  Not(ch) just development: Notch signalling in the adult brain.

Authors:  Jessica L Ables; Joshua J Breunig; Amelia J Eisch; Pasko Rakic
Journal:  Nat Rev Neurosci       Date:  2011-05       Impact factor: 34.870

5.  REST regulates oncogenic properties of glioblastoma stem cells.

Authors:  Mohamed M Kamal; Pratheesh Sathyan; Sanjay K Singh; Pascal O Zinn; Anantha L Marisetty; Shoudan Liang; Joy Gumin; Hala Osman El-Mesallamy; Dima Suki; Howard Colman; Gregory N Fuller; Frederick F Lang; Sadhan Majumder
Journal:  Stem Cells       Date:  2012-03       Impact factor: 6.277

6.  Hypoxia is important in the biology and aggression of human glial brain tumors.

Authors:  Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

7.  Necrosis as a prognostic factor in glioblastoma multiforme.

Authors:  F G Barker; R L Davis; S M Chang; M D Prados
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

8.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  16 in total

1.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.

Authors:  Jing Zhang; Cang Liu; Ruiguang Hou
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

2.  Periarteriolar Glioblastoma Stem Cell Niches Express Bone Marrow Hematopoietic Stem Cell Niche Proteins.

Authors:  Vashendriya V V Hira; Jill R Wormer; Hala Kakar; Barbara Breznik; Britt van der Swaan; Renske Hulsbos; Wikky Tigchelaar; Zbynek Tonar; Mohammed Khurshed; Remco J Molenaar; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2018-01-03       Impact factor: 2.479

Review 3.  WNT signaling in glioblastoma and therapeutic opportunities.

Authors:  Yeri Lee; Jin-Ku Lee; Sun Hee Ahn; Jeongwu Lee; Do-Hyun Nam
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

Review 4.  Contemporary murine models in preclinical astrocytoma drug development.

Authors:  Robert S McNeill; Mark Vitucci; Jing Wu; C Ryan Miller
Journal:  Neuro Oncol       Date:  2014-09-21       Impact factor: 12.300

5.  Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.

Authors:  Shailendra Kumar Dhar Dwivedi; Soumyajit Banerjee Mustafi; Lingegowda S Mangala; Dahai Jiang; Sunila Pradeep; Cristian Rodriguez-Aguayo; Hui Ling; Cristina Ivan; Priyabrata Mukherjee; George A Calin; Gabriel Lopez-Berestein; Anil K Sood; Resham Bhattacharya
Journal:  Oncotarget       Date:  2016-03-22

6.  Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide.

Authors:  Birgit C Weyhenmeyer; Janis Noonan; Maximilian L Würstle; Frank A Lincoln; Grainne Johnston; Markus Rehm; Brona M Murphy
Journal:  Oncotarget       Date:  2016-09-20

Review 7.  Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables.

Authors:  Patrick Weyerhäuser; Sven R Kantelhardt; Ella L Kim
Journal:  Front Oncol       Date:  2018-08-27       Impact factor: 6.244

Review 8.  Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.

Authors:  Xuejia Tang; Chenghai Zuo; Pengchao Fang; Guojing Liu; Yongyi Qiu; Yi Huang; Rongrui Tang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

9.  Cancer Stem Cells: Plasticity Works against Therapy.

Authors:  T V Vinogradova; I P Chernov; G S Monastyrskaya; L G Kondratyeva; E D Sverdlov
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

Review 10.  The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.

Authors:  Sandra Valle; Laura Martin-Hijano; Sonia Alcalá; Marta Alonso-Nocelo; Bruno Sainz
Journal:  Cancers (Basel)       Date:  2018-01-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.